PhD positions in a MSCA doctoral training network about targeting RNA with small molecules (TargetRNA)
Main content
Background
In recent years it became increasingly evident that RNAs constitute promising macromolecular drug targets for small molecule drugs. By targeting upstream RNA, current undruggable protein-mediated pathways could be effectively modulated thereby opening for innovative therapies that may redefine the treatment strategies for a range of conditions.
The TargetRNA doctoral training network brings together expertise and methods from molecular biology, structural biology, biophysics, computational chemistry, synthetic and medicinal chemistry, and microbiology, all the way up to in vivo models to discover new small molecule RNA ligands for selected targets and to characterize the effects of these RNA ligands on microbes and the microbiome. More information about the research programme can be found here.
The network will train the doctoral candidates (DCs) with cutting-edge interdisciplinary skills in the discovery and characterization of RNA ligands and the translation of these discoveries into innovations. Thus, TargetRNA will deliver a cohort of scientists with an interdisciplinary mind and skill set who are keen and able to push RNA-targeted drug discovery forward. Furthermore, TargetRNA will train the DCs also more broadly within structural biology, medicinal chemistry, microbiology and drug discovery, in addition to equipping them with transferable skills like FAIR data principles, and responsible development and sustainable implementation of new innovations. More information about the training program can be found here and the host institutions here.
Positions
We have filled most positions in the first hiring round.
Currently, we are inviting applications for DC5. More information about the position can be found here.
